Review
Open access
Sep 2026
Breaking the deadlock of metallo-β-lactamases: evidence and prospects for Aztreonam/Avibactam
ABSTRACT Multidrug-resistant Gram-negative bacteria pose a significant threat to global public health, with resistance mediated by metallo-β-lactamases being particularly prominent. Aztreonam/avibactam (AZA), a novel β-lactam/β-lactamase inhibitor combination, had been approved in China and the European Union for treat...
Jun-Xin Zhou, Rui Weng, Yi-Ning Ye et al.
· Emerging Microbes and Infect... · 0 citations